{
    "response": "Investigations should confirm optic nerve inflammation, exclude compressive or ischemic pathology, and search for systemic demyelinating or inflammatory disease while providing baseline data before high-dose steroid therapy.\n\ninvestigations = [\"Urgent comprehensive ophthalmologic assessment including dilated fundus examination\", \"MRI of brain, orbits, and cervical spine with gadolinium\", \"Automated visual field testing (e.g., Humphrey perimetry)\", \"Optical coherence tomography of retinal nerve fiber layer\", \"Visual evoked potentials\", \"Colour vision testing (Ishihara plates)\", \"Full blood count\", \"Urea and electrolytes\", \"Liver function tests\", \"C-reactive protein\", \"Erythrocyte sedimentation rate\", \"Blood glucose\", \"HbA1c\", \"Lipid profile\", \"Vitamin B12\", \"Serum folate\", \"Serum angiotensin-converting enzyme level\", \"Antinuclear antibody\", \"Extractable nuclear antigen panel\", \"Antineutrophil cytoplasmic antibodies\", \"Syphilis serology (treponemal antibody and VDRL or RPR)\", \"HIV serology\", \"Aquaporin-4 (AQP4-IgG) antibody\", \"Myelin oligodendrocyte glycoprotein (MOG-IgG) antibody\", \"Lyme disease serology (Borrelia burgdorferi antibodies) if epidemiologically indicated\", \"Chest X-ray\", \"Lumbar puncture with cerebrospinal fluid analysis including cell count, protein, glucose, oligoclonal bands, IgG index, cytology, and infectious studies as indicated\", \"Blood pressure measurement and cardiovascular risk assessment\"]"
}